Indication
Cocaine Abuse
4 clinical trials
9 products
Clinical trial
A Single-Blind, Randomized Study Comparing The Efficacy And Safety Of A Single Dose Of TNX-1300 To Placebo With Usual Care For The Treatment Of Signs And Symptoms Of Acute Cocaine Intoxication In Emergency Department Subjects (CATALYST Study)Status: Not yet recruiting, Estimated PCD: 2024-06-04
Product
PlaceboProduct
TNX-1300Clinical trial
Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Clavulanic AcidStatus: Completed, Estimated PCD: 2018-05-25
Product
Clavulanic acidProduct
Intravenous cocaineClinical trial
General Evaluation of Eligibility for Substance Abuse/Dependence ResearchStatus: Recruiting, Estimated PCD: 2026-06-01
Product
modafinilProduct
d-amphetamineProduct
L-DopaProduct
NaltrexoneProduct
Brain Dopamine Reactivity